Literature DB >> 3350845

Correlation between size and external temperature in four rat tumours after treatment with cytostatic agents.

P Nickers1, L Oosters, F Brasseur, I Kunkler, H Maisin, C Deckers.   

Abstract

The reduction in size of four experimental tumours (ISIS 130 and ISIS 208 immunocytomas, S 437 mammary adenocarcinoma, S 447 colon adenocarcinoma) was investigated in LOU rats under the influence of cytostatic agents belonging to different classes (5-fluorouracil, methotrexate, vinblastine, cisplatin, doxorubicin, cyclophosphamide). External tumour and rectal temperatures were measured at the same time, twice daily, during the whole experiment. With the rectal temperature of the rats kept constant, the reduction in tumour dimensions following chemotherapy correlated via a linear relationship with the duration and degree of tumour hypothermia for the three tumours S 437, ISIS 208, ISIS 130. However, for the same reduction in tumour volume following chemotherapy, the duration and degree of transient tumour hypothermia varied according to the type of tumour and cytostatic agent studied. There was not correlation between the decrease in size of S 447 and external tumour hypothermia. Even when the reduction in tumour size was statistically significant, the hypothermic tumour phase after drug administration was not sufficient to be significant, except for vinblastine. However, the temperature of this slowly growing tumour before chemotherapy was particularly low. The measurement of the degree and duration of external tumour hypothermia of tumours following chemotherapy would represent a new physiological technique for measuring the efficacy and duration of action of cytostatic agents.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3350845     DOI: 10.1007/bf00390489

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  13 in total

1.  The thermoprofile as an early indicator of breast cancer response to hormonal therapy.

Authors:  B A Stoll
Journal:  Cancer       Date:  1971-06       Impact factor: 6.860

2.  The use of isoprenaline in experimental hyperthermia.

Authors:  K Volenec; J Vodicka; P Kuna
Journal:  Neoplasma       Date:  1984       Impact factor: 2.575

3.  Heat transfer and blood flow in experimental tumors in rats compared with the circadian temperature rhythm of the body.

Authors:  U Møller; J Bojsen
Journal:  Ann N Y Acad Sci       Date:  1980       Impact factor: 5.691

4.  Blood flow and heat transfer in Walker 256 mammary carcinoma.

Authors:  R K Jain; F H Grantham; P M Gullino
Journal:  J Natl Cancer Inst       Date:  1979-04       Impact factor: 13.506

5.  Growth kinetics and in vivo radiosensitivity in nude mice of two subpopulations derived from a single human small cell carcinoma of the lung.

Authors:  M Spang-Thomsen; M Clerici; S A Engelholm; L L Vindeløv
Journal:  Eur J Cancer Clin Oncol       Date:  1986-05

6.  Temperature gradients and local perfusion in a mammary carcinoma.

Authors:  P M Gullino; R K Jain; F H Grantham
Journal:  J Natl Cancer Inst       Date:  1982-03       Impact factor: 13.506

7.  [Thermogenesis of mammary epitheliomas. III. Study, by means of fluvography, of the termal conductivity of mammary tissue and of the influence of tumor vascularization].

Authors:  M Gautherie; Y Qenneville; C H Gros
Journal:  Biomedicine       Date:  1975-05

Review 8.  A transplantable immunocytoma of the rat as a model for the study of immunoglobulin secretion.

Authors:  C Deckers; L Deckers-Passau; F Dubucq-mace
Journal:  Lab Anim Sci       Date:  1977-10

9.  Sensitivity of the hormone dependent MXT-mouse mammary carcinoma to estradiol during tumoral growth. An autoradiographic study.

Authors:  R Kiss; R Paridaens; G Leclercq; A Danguy
Journal:  Eur J Cancer Clin Oncol       Date:  1986-07

10.  Correlation between size and external temperature of the ISIS 130 tumour after treatment with cytostatic agents.

Authors:  P Nickers; L Oosters; F Brasseur; L Deckers-Passau; H Maisin; C Deckers
Journal:  Br J Cancer       Date:  1986-07       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.